Lumicell announced that an FDA advisory committee voted in support of the benefit-risk profile of its LumiSight offering. LumiSight, an optical imaging agent, works in combination with the Lumicell direct visualization system (DVS) in breast cancer imaging. The combination product — a fluorescence-guided surgical imaging tool — detects residual cancer in real-time during a lumpectomy. […]
Mammography
SimBioSys wins FDA nod for TumorSight precision medicine platform
SimBioSys announced that it received FDA 510(k) clearance for its TumorSight cloud-based digital precision medicine platform. FDA clearance came just days after the company inked a partnership with Mayo Clinic to develop precision medicine solutions. The TumorSight platform takes a patient’s standard-of-care imaging to build a custom 3D model of their tumor. The tool provides […]
SimBioSys, Mayo Clinic partner on AI-powered tech for breast cancer patients
SimBioSys announced today that it entered into a strategic collaboration with Mayo Clinic to develop digital precision medicine solutions. The collaboration aims to develop cloud-based clinical software to support end-to-end decision-making for early-stage breast cancer patients. This includes individualized surgical planning, treatment, drug selection and risk stratification. As part of the collaboration, SimBioSys has had […]
GE HealthCare unveils AI-powered breast cancer detection suite
GE HealthCare announced today that it launched a new, all-in-one AI platform to support breast cancer detection. The initial release of the GE HealthCare MyBreastAI Suite integrates three AI applications from iCad. That includes the ProFound AI for DBT, part of a platform that iCad today said demonstrates accurate breast cancer risk detection. It also […]
iCad AI tech accurately predicts breast cancer risk, provides heart disease insights
iCad (Nasdaq:ICAD) today announced plans to present new studies validating its AI-powered ProFound Breast Health Suite. ProFound helps to uncover hidden heart or vascular disease and predict a woman’s risk for developing breast cancer in the next 1-2 years. The platform can screen a single mammogram for two of the top causes of death for […]
Clarix Imaging raises $10M for surgical oncology imaging tech
Clarix Imaging announced that it secured $10 million in funding to support its volumetric specimen imaging system. The state-of-the-art, point-of-care 3D imaging platform enables the real-time assessment of surgical specimens in the operating room. Its uses include oncology, with the potential to benefit the 300,000 patients diagnosed with breast cancer in the U.S. each year. […]
Hologic launches global outreach partnership for Breast Cancer Awareness Month
Hologic today announced a series of activities for October — Breast Cancer Awareness Month. The slate of activities promotes the importance of breast cancer screenings. It includes a global partnership with Know Your Lemons, a non-profit committed to improving early breast cancer detection. Know Your Lemons provides creative and empowering education on the topic. Marlborough, […]
Hologic, Bayer partner on improved mammography imaging
Hologic and Bayer today announced an international partnership focused on improving breast cancer detection. The companies teamed up to deliver contrast-enhanced mammography (CEM) solutions across Europe, Canada and Asia Pacific. CEM, a highly sensitive, relatively low-cost breast imaging modality, combines digital mammography with contrast agent administration. It supports breast cancer diagnosis and guides treatment decisions. […]
iCad to integrate Google AI into mammography workflow
iCad (Nasdaq:ICAD) announced today that it amended its development and commercialization agreement with Google Health. The amendment enables iCad to integrate Google’s AI technology with its ProFound Breast Health Suite for 2D mammography. It intends to integrate the AI capabilities upon regulatory approval as an independent reader for breast cancer screening. ProFound Detection, a high-performance […]
iCad, Solis Mammography partner on AI for cardiovascular disease
iCad (Nasdaq:ICAD) announced today that it entered into a collaboration with Solis Mammography to define cardiovascular risk. The development and commercial collaboration revolves around producing an artificial intelligence (AI) solution. This solution potentially quantifies the presence of breast arterial calcifications in a mammogram to assess the risk of cardiovascular disease (CVD). It uses data obtained […]
Sidekick Health and Eli Lilly partner on digital therapeutics for breast cancer
Sidekick Health today announced a collaboration on an integrated digital therapeutics solution in conjunction with Eli Lilly (NYSE:LLY). The collaboration between the companies will mark the first phase of a relationship between Sidekick and Lilly, which starts with a digital therapeutic offering for patients battling breast cancer. According to a news release, the first phase […]